APA (7th ed.) Citation

Dettling, S., Stamova, S., Warta, R., Schnölzer, M., Rapp, C., Rathinasamy, A., . . . Herold-Mende, C. (2018). Identification of CRKII, CFL1, CNTN1, NME2, and TKT as novel and frequent T-cell targets in human IDH-mutant Glioma. Clinical cancer research, 24(12), . https://doi.org/10.1158/1078-0432.CCR-17-1839

Chicago Style (17th ed.) Citation

Dettling, Steffen, et al. "Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-cell Targets in Human IDH-mutant Glioma." Clinical Cancer Research 24, no. 12 (2018). https://doi.org/10.1158/1078-0432.CCR-17-1839.

MLA (9th ed.) Citation

Dettling, Steffen, et al. "Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-cell Targets in Human IDH-mutant Glioma." Clinical Cancer Research, vol. 24, no. 12, 2018, https://doi.org/10.1158/1078-0432.CCR-17-1839.